Preliminary 3-Year Evaluation of Experience With SilkSurface and VelvetSurface Motiva Silicone Breast Implants: A Single-Center Experience With 5813 Consecutive Breast Augmentation Cases

Abstract

BackgroundSilicone breast implants have been in use for breast augmentation for more than 50 years, but technological innovation has been lacking in implant design until recently.ObjectivesThis study was designed to evaluate the complication and reoperation rates following breast augmentation utilizing the Motiva silicone breast implants.MethodsThis retrospective study evaluated the safety of Motiva implants in 5813 consecutive cases of breast augmentation. Implants with two different textured surfaces were evaluated: SilkSurface (nanotextured) and VelvetSurface (micro-textured).ResultsImplants were placed between April 2013 and April 2016. A total of 44 complications were reported, with an overall complication rate of 0.76%, and the rate of reoperation was 0.76% over an interval of 3 years. There were no late complications and no cases of primary capsular contracture. No differences in complication rates were observed because of the implant date. However, among patients who received implants 300 to 499 cc in volume, complication rates were significantly lower with SilkSurface compared with VelvetSurface implants. Advanced statistical analysis supported the validity of the low complication rate reported in this study.ConclusionsOverall, these findings suggest that Motiva silicone breast implants are associated with very low rates of complication and reoperation, and that the nano-textured SilkSurface implant is associated with fewer complications than micro-textured implants.Level of Evidence: 3

Breast augmentation surgery: Clinical considerations

“…The fi rst silicone gel implants, introduced in the early 1960s, [8][9][10][11][12][13][14][15][16][17][18][19] had high complication rates-some centers reported an incidence of capsular contracture of up to 70%. 8,11 This is a foreign body reaction in which pathologic scar tissue encases the implant, causing it to distort, appear misshapen, harden, and even become painful.…”

“…It also contains radio-frequency identifi cation transponders that can transmit data about the implant wirelessly. [17][18][19] Surface (textured vs smooth) Developed in the 1980s, texturing of the implant surface disrupts capsule formation around the prosthesis. Additionally, texturing stabilizes an anatomically shaped (teardrop) implant within the breast pocket, reducing malrotation.…”

Current Approaches Including Novel Nano/Microtechniques to Reduce Silicone Implant-Induced Contracture with Adverse Immune Responses

“…Sforza et al [ 121 ] performed a preliminary 3-year evaluation of nano/microtextured silicone breast implants. In this study, the nano/microtextured breast implants were constructed with a uniform topography using three-dimensional imprinting of PDMS to create optimized biocompatible outer shells.…”

“…In this study, the nano/microtextured breast implants were constructed with a uniform topography using three-dimensional imprinting of PDMS to create optimized biocompatible outer shells. Fabrication was particle-free and did not use extrusion of foreign material to create the surface geometry, thus enabling a uniform and controlled shell thickness ( Figure 11 ) [ 121 ]. The physical characteristics of the nano/microtextured surfaces are presented in Table 1 .…”

Research Related to Capsular Contracture after Breast Augmentation for Cosmetic or Reconstructive Purposes

“…The introduction of the textured surface was an important development related to the silicone breast prostheses, significantly reducing the rate of the fibrotic complications such as capsular contracture. However, recent data from the literature show that this type of surface can be associated with the appearance of BIA-ALCL [8], a factor that have led to the introduction of the micro-or nanotextured surface concept [9], which has the advantage of decreasing the capsular contracture rate by inhibiting the foreign body-type immune response [10], while reducing the risk of BIA-ALCL. Additional studies and a long-term analysis related to this relatively new type of breast implants are required in order to identify the characteristics of the relationship between this type of implant surface, the capsular contracture rate and the risks of BIA-ALCL occurrence.…”